08:52 AM EDT, 03/26/2025 (MT Newswires) -- US equity futures were flat ahead of Wednesday's opening bell as traders awaited President Donald Trump's announcement next week on reciprocal trade tariffs.

The Dow Jones Industrial Average futures gained 0.1%, S&P 500 futures flatlined, and Nasdaq futures were down 0.1%.

Investors remained focused on tariffs as the Trump administration attempts to reshape US trade policy. The White House is expected to deploy additional measures on April 2.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.9% at $73.00 per barrel and US West Texas Intermediate crude up 0.9% at $69.62 per barrel.

New orders for durable goods, released at 8:30 am ET, rose by 0.9% in February following a 3.3% jump in January, compared with estimates compiled by Bloomberg for a 1% decline.

In other world markets, Japan's Nikkei closed 0.7% higher, Hong Kong's Hang Seng ended 0.6% higher, and China's Shanghai Composite finished 0.04% lower. Meanwhile, the UK's FTSE 100 gained 0.3%, and Germany's DAX index fell 0.5% in Europe's early afternoon session.

In equities, shares of TechnipFMC ( FTI ) were 1.4% higher pre-bell after the company said late Tuesday it secured a "major" contract from Shell (SHEL) for its Gato do Mato project in offshore Brazil. SurgePays ( SURG ) stock was 76% higher, a day after the company said it expects revenue to exceed $200 million over the next 12 months, compared with 2024 revenue of $60.9 million.

On the losing side, Humacyte ( HUMA ) shares slumped 30% after the company said late Tuesday it priced a $50 million stock offering.